These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

912 related articles for article (PubMed ID: 12226754)

  • 1. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
    Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
    Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
    Jazirehi AR; Huerta-Yepez S; Cheng G; Bonavida B
    Cancer Res; 2005 Jan; 65(1):264-76. PubMed ID: 15665303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells.
    Chiao PJ; Na R; Niu J; Sclabas GM; Dong Q; Curley SA
    Cancer; 2002 Oct; 95(8):1696-705. PubMed ID: 12365017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.
    Huerta-Yepez S; Vega M; Jazirehi A; Garban H; Hongo F; Cheng G; Bonavida B
    Oncogene; 2004 Jun; 23(29):4993-5003. PubMed ID: 15048072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
    Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV
    Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib.
    Fahy BN; Schlieman MG; Mortenson MM; Virudachalam S; Bold RJ
    Cancer Chemother Pharmacol; 2005 Jul; 56(1):46-54. PubMed ID: 15791457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboplatin induces apoptotic cell death through downregulation of constitutively active nuclear factor-kappaB in human HPV-18 E6-positive HEp-2 cells.
    Singh S; Bhat MK
    Biochem Biophys Res Commun; 2004 May; 318(2):346-53. PubMed ID: 15120608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated inhibition of NF-kappaB confers chemo-sensitization and apoptosis in prostate cancer cells.
    Flynn V; Ramanitharan A; Moparty K; Davis R; Sikka S; Agrawal KC; Abdel-Mageed AB
    Int J Oncol; 2003 Aug; 23(2):317-23. PubMed ID: 12851680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
    Frankel A; Man S; Elliott P; Adams J; Kerbel RS
    Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-kappaB and upregulation of BCL-2 and BCL-XL.
    Konishi T; Sasaki S; Watanabe T; Kitayama J; Nagawa H
    Oncogene; 2006 May; 25(22):3160-9. PubMed ID: 16407826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells.
    Ling MT; Wang X; Ouyang XS; Xu K; Tsao SW; Wong YC
    Oncogene; 2003 Jul; 22(29):4498-508. PubMed ID: 12881706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X; Kandasamy K; Srivastava RK
    Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells.
    Kim H; Chung H; Kim HJ; Lee JY; Oh MY; Kim Y; Kong G
    Breast Cancer Res Treat; 2008 Nov; 112(2):287-96. PubMed ID: 18158619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
    Todaro M; Zerilli M; Triolo G; Iovino F; Patti M; Accardo-Palumbo A; di Gaudio F; Turco MC; Petrella A; de Maria R; Stassi G
    Arthritis Rheum; 2005 Jul; 52(7):2179-91. PubMed ID: 15986355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer.
    Mortenson MM; Schlieman MG; Virudachalam S; Lara PN; Gandara DG; Davies AM; Bold RJ
    Lung Cancer; 2005 Aug; 49(2):163-70. PubMed ID: 16022909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
    Shehata M; Shehata M; Shehata F; Pater A
    Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
    Uwagawa T; Li Z; Chang Z; Xia Q; Peng B; Sclabas GM; Ishiyama S; Hung MC; Evans DB; Abbruzzese JL; Chiao PJ
    Cancer; 2007 May; 109(10):2142-53. PubMed ID: 17410536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
    Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
    Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function of nuclear factor kappaB in pancreatic cancer metastasis.
    Fujioka S; Sclabas GM; Schmidt C; Frederick WA; Dong QG; Abbruzzese JL; Evans DB; Baker C; Chiao PJ
    Clin Cancer Res; 2003 Jan; 9(1):346-54. PubMed ID: 12538487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.